参考文献/References:
[1] Go AS,Mozaffarian D,Roger VL,et al.Heart disease and stroke statistics--2013 update: a report from the American Heart Association[J].Circulation,2013,127(1):e6-e245.
[2] Wang J,Zhang J,Ye Y,et al.Peripheral organ injury after stroke[J].Front Immunol,2022:13.
[3] Structure CMN.Function and histology of the spleen[J].Toxicol Pathol,2006,34(5):455-465.
[4] Chiu NL,Kaiser B,Nguyen YV,et al.The volume of the spleen and its correlates after acute stroke[J].J Stroke Cerebrovasc Dis,2016,25(12):2958-2961.
[5] Alahmari A.Blood-brain barrier overview: structural and functional correlation[J].Neural Plast,2021,2021:6564585.
[6] Galea I.The blood-brain barrier in systemic infection and inflammation[J].Cell Mol Immunol,2021,18(11):2489-2501.
[7] Yang CJ,Hawkins KE,Doré S,et al.Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke[J].Am J Physiol Cell Physiol,2019,316(2):C135-C153.
[8] Ren XF,Simpkins JW.Deciphering the Blood-brain barrier damage in stroke: mitochondrial mechanism[J].J Neuroinfect Dis,2015,6(Suppl 2):e002.
[9] Doll DN,Hu H,Sun JH,et al.Mitochondrial crisis in cerebrovascular endothelial cells opens the blood-brain barrier[J].Stroke,2015,46(6):1681-1689.
[10] Ma YZ,Yang SL,He QY,et al.The role of immune cells in post-stroke angiogenesis and neuronal remodeling: the known and the unknown[J].Front Immunol,2021,12:784098.
[11] Yang FX,Zhao K,Zhang XF,et al.ATP induces disruption of tight junction proteins via IL-1 Beta-dependent MMP-9 activation of human blood-brain barrier in vitro[J].Neural Plast,2016,2016:8928530.
[12] Heo JH,Han SW,Lee SK.Free radicals as triggers of brain edema formation after stroke[J].Free Radic Biol Med,2005,39(1):51-70.
[13] Seifert HA,Hall AA,Chapman CB,et al.A transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulation[J].J Neuroimmune Pharmacol,2012,7(4):1017-1024.
[14] Nous A,Peeters I,Nieboer K,et al.Post-stroke infections associated with spleen volume reduction: a pilot study[J].PLoS One,2020,15(5):e0232497.
[15] Offner H,Subramanian S,Parker SM,et al.Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages[J].J Immunol,2006,176(11):6523-6531.
[16] Wang Z,He D,Zeng YY,et al.The spleen may be an important target of stem cell therapy for stroke[J].J Neuroinflammation,2019,16(1):20.
[17] Chen Y,Hallenbeck JM,Ruetzler C,et al.Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells[J].J Cereb Blood Flow Metab,2003,23(6):748-755.
[18] Huitinga I,van Rooijen N,de Groot CJ,et al.Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages[J].J Exp Med,1990,172(4):1025-1033.
[19] Schmidt A,Strecker JK,Hucke S,et al.Targeting different monocyte/macrophage subsets has no impact on outcome in experimental stroke[J].Stroke,2017,48(4):1061-1069.
[20] Li PY,Gan Y,Sun BL,et al.Adoptive regulatory T-cell therapy protects against cerebral ischemia[J].Ann Neurol,2013,74(3):458-471.
[21] Westendorp WF,Zock E,Vermeij JD,et al.Preventive antibiotics in stroke study(PASS): a cost-effectiveness study[J].Neurology,2018,90(18):e1553-e1560.
[22] Kalra L,Irshad S,Hodsoll J,et al.Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia(STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial[J].Lancet,2015,386(10006):1835-1844.
[23] Meisel C,Schwab JM,Prass K,et al.Central nervous system injury-induced immune deficiency syndrome[J].Nat Rev Neurosci,2005,6(10):775-786.
[24] Bonaz B,Sinniger V,Pellissier S.Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation[J].J Physiol,2016,594(20):5781-5790.
[25] Felten DL,Felten SY,Bellinger DL,et al.Noradrenergic sympathetic neural interactions with the immune system:structure and function[J].Immunol Rev,1987,100:225-260.
[26] Sanders VM,Baker RA,Ramer-Quinn DS,et al.Differential expression of the β2-adrenergic receptor by Th1 and Th2 clones:implications for cytokine production and B cell help[J].Immunol,1997,158(9):4200-4210.
[27] Dokur M,Boyadjieva N,Sarkar DK.Catecholaminergic control of NK cell cytolytic activity regulatory factors in the spleen[J].J Neuroimmunol,2004,151(1/2):148-157.
[28] Shimba A,Ikuta K.Control of immunity by glucocorticoids in health and disease[J].Semin Immunopathol,2020,42(6):669-680.
[29] Sundbøll J,Horváth-Puhó E,Schmidt M,et al.Preadmission use of glucocorticoids and 30-day mortality after stroke[J].Stroke,2016,47(3):829-835.
[30] Pohanka M.Pharmacological influencing of the cholinergic anti-inflammatory pathway in infectious diseases and inflammatory pathologies[J].Mini Rev Med Chem,2021,21(6):660-669.
[31] Mehranfard D,Speth RC.Cholinergic anti-inflammatory pathway and COVID-19[J].Bioimpacts,2022,12(2):171-174.
[32] Shenhar-Tsarfaty S,Berliner S,Bornstein NM,et al.Cholinesterases as biomarkers for parasympathetic dysfunction and inflammation-related disease[J].J Mol Neurosci,2014,53(3):298-305.
[33] Haeusler KG,Schmidt WUH,Föhring F,et al.Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans[J].Cerebrovasc Dis,2008,25(1/2):50-58.
[34] Chen CY,Chao YM,Lin HF,et al.miR-195 reduces age-related blood-brain barrier leakage caused by thrombospondin-1-mediated selective autophagy[J].Aging Cell,2020,19(11):e13236.
[35] Li YC,Zhong W,Jiang Z,et al.New progress in the approaches for blood-brain barrier protection in acute ischemic stroke[J].Brain Res Bull,2019,144:46-57.
[36] Qu Y,Wang L,Mao YF.Gallic acid attenuates cerebral ischemia/re-perfusion-induced blood-brain barrier injury by modifying polarization of microglia[J].J Immunotoxicol,2022,19(1):17-26.
[37] Suda S,Igarashi H,Arai Y,et al.Effect of edaravone, a free radical scavenger, on ischemic cerebral edema assessed by magnetic resonance imaging[J].Neurol Med Chir(Tokyo),2007,47(5):197-201; discussion 201-2.
[38] Tang HL,Li Y,Tang WJ,et al.Correction to: endogenous neural stem cell-induced neurogenesis after ischemic stroke: processes for brain repair and perspectives[J].Transl Stroke Res,2023,14(6):1007.
[39] Vendrame M,Cassady J,Newcomb J,et al.Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume[J].Stroke,2004,35(10):2390-2395.
[40] Borlongan CV,Hadman M,Sanberg CD,et al.Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke[J].Stroke,2004,35(10):2385-2389.
[41] Newcomb JD,Ajmo CTJ,Sanberg CD,et al.Timing of cord blood treatment after experimental stroke determines therapeutic efficacy[J].Cell Transplant,2006,15(3):213-223.
[42] Li YJ,Dong YK,Ran Y,et al.Three-dimensional cultured mesenchymal stem cells enhance repair of ischemic stroke through inhibition of microglia[J].Stem Cell Res Ther,2021,12(1):358.
[43] Uchida K,Kawaja MD,Toya S,et al.Transgenic neural plate contributes neuronal cells that survive greater than one year when transplanted into the adult mouse central nervous system[J].Exp Neurol,1995,132(2):194-208.
[44] Fukunaga A,Uchida K,Hara K,et al.Differentiation and angiogenesis of central nervous system stem cells implanted with mesenchyme into ischemic rat brain[J].Cell Transplant,1999,8(4):435-441.
[45] Wu YJ,Li JX,Shou JY,et al.Diverse functions and mechanisms of regulatory T cell in ischemic stroke[J].Exp Neurol,2021,343:113782.
[46] Yang HN,Zhang AX,Zhang YQ,et al.Resveratrol pretreatment protected against cerebral ischemia/reperfusion injury in rats via expansion of T regulatory cells[J].J Stroke Cerebrovasc Dis,2016,25(8):1914-1921.
[47] Yuan CL,Shi LG,Sun ZY,et al.Regulatory T cell expansion promotes white matter repair after stroke[J].Neurobiol Dis,2023,179:106063.
[48] Wang Z,Zhou Y,Yu Y,et al.Lipopolysaccharide preconditioning increased the level of regulatory B cells in the spleen after acute ischaemia/reperfusion in mice[J].Brain Res,2018,1701:46-57.
[49] Garcia-Bonilla L,Brea D,Benakis C,et al.Endogenous protection from ischemic brain injury by preconditioned monocytes[J].J Neurosci,2018,38(30):6722-6736.
[50] Ran YY,Liu ZJ,Huang S,et al.Splenectomy fails to provide long-term protection against ischemic stroke[J].Aging Dis,2018,9(3):467-479.
[51] Chen C,Jiang W,Liu ZJ,et al.Splenic responses play an important role in remote ischemic preconditioning-mediated neuroprotection against stroke[J].J Neuroinflammation,2018,15(1):167.
[52] Cheng X,Zhao HP,Yan F,et al.Limb remote ischemic post-conditioning mitigates brain recovery in a mouse model of ischemic stroke by regulating reactive astrocytic plasticity[J].Brain Res,2018,1686:94-100.
[53] Ajmo CTJ,Collier LA,Leonardo CC,et al.Blockade of adrenoreceptors inhibits the splenic response to stroke[J].Exp Neurol,2009,218(1):47-55.
[54] Jin R,Zhu XL,Liu L,et al.Simvastatin attenuates stroke-induced splenic atrophy and lung susceptibility to spontaneous bacterial infection in mice[J].Stroke,2013,44(4):1135-1143.